Literature DB >> 2412485

Immunofluorescence study of patients with neuropathy and IgM M proteins.

M Takatsu, A P Hays, N Latov, G M Abrams, R Nemni, W H Sherman, E Nobile-Orazio, T Saito, L Freddo.   

Abstract

Immunofluorescence histochemistry was used to study the pathogenesis of polyneuropathy in patients with an IgM M protein. Seventeen patients had an M protein that reacted with myelin-associated glycoprotein (MAG), and their serum immunostained myelin sheaths of normal peripheral nerve of humans and certain other species. The staining was specific for the M protein idiotype and was abolished by prior absorption of serum with MAG. The sural nerve biopsy specimens from these 17 patients had pathological features of primary demyelination and deposits of IgM on the myelin sheaths. Sural nerve specimens of 2 patients with an M protein reactive with chondroitin sulfate showed axonal degeneration and diffuse deposits of IgM in the endoneurium. Serum of one of these patients immunostained connective tissue; the staining was specific for the M protein idiotype and was blocked by absorption of the serum with chondroitin sulfate. The antigenic specificity of the IgM M protein in another 9 patients with neuropathy is not known; however, sural nerve specimens obtained from some of the patients showed axonal degeneration and endoneurial deposits of IgM, and the serum IgM immunostained axons in some instances. The findings suggest that IgM M proteins may cause the neuropathy and that more than one autoantigen is involved.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412485     DOI: 10.1002/ana.410180203

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

3.  Binding of monoclonal anti-myelin-associated glycoprotein antibodies to human foetal peripheral neurons in culture.

Authors:  G Moretto; S Monaco; E Nardelli; E Arlacchi; I Stoppelli; N Rizzuto
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 4.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

Review 5.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Authors:  Michael Pt Lunn; Eduardo Nobile-Orazio
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

Review 6.  Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.

Authors:  E Ellie; A Vital; A Steck; J M Boiron; C Vital; J Julien
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

7.  Axonal neuropathy associated with monoclonal gammopathy of undetermined significance.

Authors:  K C Gorson; A H Ropper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

8.  Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier.

Authors:  F P Thomas; W Trojaborg; C Nagy; M Santoro; S A Sadiq; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy.

Authors:  B Lach; P Rippstein; D Atack; D E Afar; A Gregor
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 10.  Developmental and pathophysiological aspects of the myelin-associated glycoprotein.

Authors:  R O Brady; R H Quarles
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.